(Press-News.org) HERSHEY, Pa. — Artificial intelligence (AI) is changing the field and practice of medicine, including legal liability and the perception of who is at fault when a patient experiences harm.
“AI holds promise to improve the quality and safety of health care and to reduce errors and patient harm, but the risk of legal liability is a potential barrier for investment and development of this technology as well as the quality of care,” said Michael Bruno, professor of radiology and of medicine at Penn State College of Medicine.
Now, Bruno, working alongside a team of researchers from Brown University and Seton Hall University School of Law, found that the understanding of physician liability is influenced by the way in which AI is integrated into a clinician’s workflow. The study was published today (MARCH 10) in the journal Nature Health.
The researchers presented mock jurors with a hypothetical malpractice case where a patient suffered irreversible brain damage because a radiologist didn’t detect a brain bleed from a computerized tomography (CT) scan, even though AI correctly identified the scan as abnormal. They found that mock jurors were almost 50% more likely to side with the plaintiff and against the radiologist when the radiologist only reviewed the CT scan once after AI flagged the scan compared to when the radiologist read the scan twice, once before receiving the AI feedback and once after.
Nearly a year ago, Bruno convened a two-day Research Summit on “Human Factors and Artificial Intelligence in Healthcare,” on the Penn State College of Medicine campus, bringing together an international group of multidisciplinary experts from academia and industry to establish future research priorities for the field of Human-AI collaboration.
“If you're a stakeholder trying to figure out whether to purchase an AI product at a hospital, whether to direct your doctors to follow a certain workflow, or whether to settle a case because an error has already occurred, this kind of information is vital because you can weigh the cost versus the benefits in a far more informed way,” said Brian Sheppard, professor of law at Seton Hall University School of Law and a co-author on the paper.
The researchers explained that they chose to look at a radiology-based case because the integration of AI into radiology practice is further along than in other areas of medicine, which means that the physician-AI interaction is a plausible scenario. Since most medical malpractice cases are settled out of court and out of the public record or, if they do go to court, take years to litigate, using a hypothetical case allows the researchers to gather information that would otherwise be unavailable.
For this study, the team recruited 282 participants who were randomized to read one of two scenarios. In the first scenario, AI flagged the case as abnormal, and the radiologist then reviewed the images once, concluding that there was no evidence of bleeding in the brain. In the second, the radiologist reviewed and interpreted the CT twice, once before receiving feedback from the AI system and then a second time after AI flagged the case as abnormal. In both instances, the radiologist concluded that there was no evidence of a brain bleed. After reading the case, participants were asked if the radiologist met their duty of care to the patient.
Nearly 75% of the mock jurors found that the radiologist did not meet their duty of care when they reviewed the CT once. However, that dropped to 53% when the radiologist reviewed the CT twice. The findings suggest that changes to radiologist workflow — when and the number of times they review and interpret imaging tests when AI is involved — could reduce legal risk, the researchers explained. However, these changes aren’t without costs.
“There are all these biases that are incentivizing radiologists not to disagree with AI because the cost of disagreeing with it is too high. If you disagree with AI and you're wrong, this will be used against you,” said co-author Grayson Baird, associate professor of radiology at Brown University and director of the Brown Radiology, Psychology, and Law Lab and the Brown Radiology Human Factors Lab. “The cost is then passed on to the patient who now has to deal with the anxiety and discomfort from follow-up care, imaging or tests. We all pay for it, too, because the cost of healthcare increases.”
While the study didn’t explore the underlying reasons behind the relationship between AI and perception of legal liability, the researchers explained that the findings show that how people determine fault when AI systems are used depends on context.
This study builds on prior work conducted by the research team where they, using the same hypothetical case, found that mock jurors were less likely to find a radiologist liable when the radiologist agreed with an AI interpretation versus when they disagreed. The perception of legal liability was also mitigated when AI error rates were presented to mock jurors versus when they were unknown to the jurors. In another study, other researchers found that AI can impact physician decision making, prompting physicians to change their mind on treatment decisions.
“How people perceive AI, and how their perception impacts human liability, is evolving quickly along with the technology. It’s something that we need to pay close attention to,” said corresponding author Michael Bernstein, associate professor of radiology at Brown University and associate director of the Brown Radiology Human Factors Lab.
END
How AI is integrated into clinical workflow lowers medical liability perception
The number of times a radiologist reviewed a case impacts perception of legal liability when they make an error while using AI
2026-03-10
ELSE PRESS RELEASES FROM THIS DATE:
New biotech company to accelerate treatments for heart disease
2026-03-10
A new biotech company forged through an Australian and Danish partnership will accelerate treatments for children and adults with heart disease. Harnessing cellular therapies, the company aims to conduct human clinical trials within three to five years.
Ibnova Therapeutics, launched today, has emerged from world-first, collaborative research by Murdoch Children’s Research Institute (MCRI) in Melbourne and QIMR Berghofer in Brisbane. Within MCRI, this work is supported by the Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), which is headquartered ...
One gene makes the difference: research team achieves breakthrough in breeding winter-hardy faba beans
2026-03-10
The faba bean is an ancient crop. It is particularly valuable because it is high in protein, and can convert nitrogen from the air into a form that can be used by plants in the soil. This makes it a sustainable alternative to soy, particularly in Europe. However, many varieties are not winter-hardy. In cold regions, they do not survive frost.
Firstly, the research team succeeded in significantly improving the reference genome of the faba bean. Various methods, such as optical mapping, were used to assemble the genome’s individual sections more precisely. “Our new ...
Predicting brain health with a smartwatch
2026-03-10
Can smartphones or smartwatches help detect early signs of neurological or mental illness? Researchers at the University of Geneva (UNIGE) monitored a group of participants wearing connected devices, and used artificial intelligence to analyse data such as heart rate, physical activity, sleep and air pollution. Their findings show that connected devices can accurately predict emotional and cognitive fluctuations, opening new avenues for the early detection of changes in brain health. The study has been published in npj Digital Medicine.
Brain health, encompassing both cognitive and emotional functions, is one of the major public health challenges of the ...
How boron helps to produce key proteins for new cancer therapies
2026-03-10
Many of the key proteins for modern medicine and science are poorly soluble. These include numerous signalling proteins and protein hormones, as well as all of the receptors anchored in the cell membranes, which are targeted by around 60 percent of the active ingredients currently used in medicines. If the concentration of these proteins exceeds a certain threshold, they clump together and lose their function.
This clumping makes it impossible to produce these molecules synthetically in the lab. As protein production with specialised synthesis robots always requires multiple fragments to be coupled into a complete protein, ...
Writing the catalog of plasma membrane repair proteins
2026-03-10
In the evolutionary history of life, the ability of a cell to separate its inner world from the external environment was an important turning point. The so-called plasma membrane lets cells control what gets in and out and allows them to communicate and cooperate with one another, creating the conditions for complex, multicellular life.
This barrier is fragile. Every day, mechanical stress, environmental changes, and bacterial toxins threaten to puncture the membrane, and if the wounds aren’t sealed and healed quickly, the cell dies. Despite its importance to the survival of our cells, the processes of plasma membrane ...
A comprehensive review charts how psychiatry could finally diagnose what it actually treats
2026-03-10
CAMBRIDGE, Cambridgeshire, UNITED KINGDOM, 10 March 2026 — A comprehensive invited review published today in Brain Medicine confronts one of the most persistent paradoxes in modern medicine: psychiatry remains the only major clinical discipline that diagnoses complex illness primarily through conversation and symptom checklists, while fields such as oncology and cardiology long ago embraced laboratory markers, imaging, and molecular profiling. The review, authored by Dr. Jakub Tomasik, Jihan K. Zaki, and Professor Sabine Bahn at the Cambridge Centre for Neuropsychiatric Research, University of Cambridge, synthesizes emerging research across conceptual frameworks, ...
Thousands of genetic variants shape epilepsy risk, and most remain hidden
2026-03-10
OSLO, Eastern Norway, NORWAY, 10 March 2026 — An insightful mini-review published in Genomic Psychiatry synthesizes the rapidly expanding landscape of molecular genetic research on common epilepsies, assembling evidence from genome-wide association studies, whole-exome sequencing projects, and advanced statistical modeling to illuminate the polygenic architecture that underpins these heterogeneous neurological disorders. The synthesis, led by Dr. Olav B. Smeland of the Centre for Precision Psychiatry at Oslo University Hospital and the University of Oslo, draws a detailed portrait ...
First comprehensive sex-specific atlas of GLP-1 in the mouse brain reveals why blockbuster weight-loss drugs may work differently in females and males
2026-03-10
NEW YORK, New York, UNITED STATES, 10 March 2026 — The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the treatment of obesity and diabetes so thoroughly that the word "blockbuster" barely covers it. And yet for all the billions of dollars spent, for all the prescriptions written, a fundamental question has lingered like a low hum beneath the clinical noise: where, precisely, does GLP-1 live inside the brain, ...
When rats run, their gut bacteria rewrite the chemical conversation with the brain
2026-03-10
CORK, Munster, IRELAND, 10 March 2026 — Something happens when a rat starts running. Not just the obvious things, the faster heart, the warming muscles, the rhythmic percussion of paws against the wheel. Something quieter. Something that begins in the coiled darkness of the gut and travels, through blood and biochemistry, all the way to the hippocampus, that seahorse-shaped sliver of tissue where memories form and moods take root. A new study published in Brain Medicine, a Genomic Press journal, ...
Movies reconstructed from mouse brain activity
2026-03-10
Scientists have successfully reconstructed videos purely from the brain activity of mice, showing what the mice were seeing, in a new study led by University College London (UCL) researchers.
The findings, published in eLife, could help shed light on the intricate workings of how the brain processes visual information and open new avenues for exploring how different species perceive the world.
Over recent years, there has been a growing interest in understanding exactly how the human brain interprets ...
LAST 30 PRESS RELEASES:
Advancing brain–computer interfaces for rehabilitation and assistive technologies
Detecting Alzheimer's with DNA aptamers—new tool for an easy blood test
Chinese Neurosurgical Journal study develops radiomics model to predict secondary decompressive craniectomy
New molecular switch that boosts tooth regeneration discovered
Jeonbuk National University researchers track mineral growth on bioorganic coatings in real time at nanoscale
Convergence in the Canopy: Why the Gracixalus weii treefrog sounds like a songbird
Subway systems are uncomfortably hot — and worsening
Granular activated carbon-sorbed PFAS can be used to extract lithium from brine
How AI is integrated into clinical workflow lowers medical liability perception
New biotech company to accelerate treatments for heart disease
One gene makes the difference: research team achieves breakthrough in breeding winter-hardy faba beans
Predicting brain health with a smartwatch
How boron helps to produce key proteins for new cancer therapies
Writing the catalog of plasma membrane repair proteins
A comprehensive review charts how psychiatry could finally diagnose what it actually treats
Thousands of genetic variants shape epilepsy risk, and most remain hidden
First comprehensive sex-specific atlas of GLP-1 in the mouse brain reveals why blockbuster weight-loss drugs may work differently in females and males
When rats run, their gut bacteria rewrite the chemical conversation with the brain
Movies reconstructed from mouse brain activity
Subglacial weathering may have slowed Earth's escape from snowball Earth
Simple test could transform time to endometriosis diagnosis
Why ‘being squeezed’ helps breast cancer cells to thrive
Mpox immune test validated during Rwandan outbreak
Scientists pinpoint protein shapes that track Alzheimer’s progression
Researchers achieve efficient bicarbonate-mediated integrated capture and electrolysis of carbon dioxide
Study reveals ancient needles and awls served many purposes
Key protein SYFO2 enables 'self-fertilization’ of leguminous plants
AI tool streamlines drug synthesis
Turning orchard waste into climate solutions: A simple method boosts biochar carbon storage
New ACP papers say health care must be more accessible and inclusive for patients and physicians with disabilities
[Press-News.org] How AI is integrated into clinical workflow lowers medical liability perceptionThe number of times a radiologist reviewed a case impacts perception of legal liability when they make an error while using AI